207 related articles for article (PubMed ID: 25609230)
21. Identification and characterization of the anti-methicillin-resistant Staphylococcus aureus WAP-8294A2 biosynthetic gene cluster from Lysobacter enzymogenes OH11.
Zhang W; Li Y; Qian G; Wang Y; Chen H; Li YZ; Liu F; Shen Y; Du L
Antimicrob Agents Chemother; 2011 Dec; 55(12):5581-9. PubMed ID: 21930890
[TBL] [Abstract][Full Text] [Related]
22. Synergistic combinations of polymyxins.
Lenhard JR; Nation RL; Tsuji BT
Int J Antimicrob Agents; 2016 Dec; 48(6):607-613. PubMed ID: 27865626
[TBL] [Abstract][Full Text] [Related]
23. Isolation and identification of a Paenibacillus polymyxa strain that coproduces a novel lantibiotic and polymyxin.
He Z; Kisla D; Zhang L; Yuan C; Green-Church KB; Yousef AE
Appl Environ Microbiol; 2007 Jan; 73(1):168-78. PubMed ID: 17071789
[TBL] [Abstract][Full Text] [Related]
24. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
Falagas ME; Kasiakou SK
Clin Infect Dis; 2005 May; 40(9):1333-41. PubMed ID: 15825037
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the amylovorin locus of Lactobacillus amylovorus DCE 471, producer of a bacteriocin active against Pseudomonas aeruginosa, in combination with colistin and pyocins.
Moreno MR; Baert B; Denayer S; Cornelis P; De Vuyst L
FEMS Microbiol Lett; 2008 Sep; 286(2):199-206. PubMed ID: 18803001
[TBL] [Abstract][Full Text] [Related]
26. Insights into an unusual nonribosomal peptide synthetase biosynthesis: identification and characterization of the GE81112 biosynthetic gene cluster.
Binz TM; Maffioli SI; Sosio M; Donadio S; Müller R
J Biol Chem; 2010 Oct; 285(43):32710-32719. PubMed ID: 20710026
[TBL] [Abstract][Full Text] [Related]
27. Contemporary assessment of antimicrobial susceptibility testing methods for polymyxin B and colistin: review of available interpretative criteria and quality control guidelines.
Gales AC; Reis AO; Jones RN
J Clin Microbiol; 2001 Jan; 39(1):183-90. PubMed ID: 11136768
[TBL] [Abstract][Full Text] [Related]
28. Identification of a polymyxin synthetase gene cluster of Paenibacillus polymyxa and heterologous expression of the gene in Bacillus subtilis.
Choi SK; Park SY; Kim R; Kim SB; Lee CH; Kim JF; Park SH
J Bacteriol; 2009 May; 191(10):3350-8. PubMed ID: 19304848
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and characterization of the colistin peptide polymyxin E1 and related antimicrobial peptides.
Kline T; Holub D; Therrien J; Leung T; Ryckman D
J Pept Res; 2001 Mar; 57(3):175-87. PubMed ID: 11298918
[TBL] [Abstract][Full Text] [Related]
30. Biosynthesis of paenibacillin, a lantibiotic with N-terminal acetylation, by Paenibacillus polymyxa.
Huang E; Yousef AE
Microbiol Res; 2015 Dec; 181():15-21. PubMed ID: 26640048
[TBL] [Abstract][Full Text] [Related]
31. Pitfalls of polymyxin antimicrobial susceptibility testing of Pseudomonas aeruginosa isolated from cystic fibrosis patients.
Hogardt M; Schmoldt S; Götzfried M; Adler K; Heesemann J
J Antimicrob Chemother; 2004 Dec; 54(6):1057-61. PubMed ID: 15509615
[TBL] [Abstract][Full Text] [Related]
32. The lipopeptide antibiotic A54145 biosynthetic gene cluster from Streptomyces fradiae.
Miao V; Brost R; Chapple J; She K; Gal MF; Baltz RH
J Ind Microbiol Biotechnol; 2006 Feb; 33(2):129-40. PubMed ID: 16208464
[TBL] [Abstract][Full Text] [Related]
33. Molecular characterization of Pseudomonas aeruginosa isolates resistant to all antimicrobial agents, but susceptible to colistin, in Daegu, Korea.
Lee YC; Ahn BJ; Jin JS; Kim JU; Lee SH; Song DY; Lee WK; Lee JC
J Microbiol; 2007 Aug; 45(4):358-63. PubMed ID: 17846591
[TBL] [Abstract][Full Text] [Related]
34. Mutant prevention concentrations of colistin for Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae clinical isolates.
Choi MJ; Ko KS
J Antimicrob Chemother; 2014 Jan; 69(1):275-7. PubMed ID: 23997018
[No Abstract] [Full Text] [Related]
35. Differences in potency and categorical agreement between colistin and polymyxin B when testing 15,377 clinical strains collected worldwide.
Sader HS; Rhomberg PR; Farrell DJ; Jones RN
Diagn Microbiol Infect Dis; 2015 Dec; 83(4):379-81. PubMed ID: 26415906
[TBL] [Abstract][Full Text] [Related]
36. Enhanced Production of Polymyxin E in
Yu Z; Sun Z; Yin J; Qiu J
Biomed Res Int; 2018; 2018():1934309. PubMed ID: 30406130
[TBL] [Abstract][Full Text] [Related]
37. Quality control guidelines for testing gram-negative control strains with polymyxin B and colistin (polymyxin E) by standardized methods.
Jones RN; Anderegg TR; Swenson JM;
J Clin Microbiol; 2005 Feb; 43(2):925-7. PubMed ID: 15695708
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of colistin as an agent against multi-resistant Gram-negative bacteria.
Li J; Nation RL; Milne RW; Turnidge JD; Coulthard K
Int J Antimicrob Agents; 2005 Jan; 25(1):11-25. PubMed ID: 15620821
[TBL] [Abstract][Full Text] [Related]
39. Combinations of antimicrobial agents. I. The in vitro sensitivity of 100 strains of Pseudomonas aeruginosa to polymyxin B, colistin, carbenicillin, gentamicin and doxycycline and to various combinations of these antibiotics.
Kuipers JS
Arch Chir Neerl; 1975; 27(4):257-70. PubMed ID: 174496
[TBL] [Abstract][Full Text] [Related]
40. Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistin.
Sader HS; Rhomberg PR; Flamm RK; Jones RN
Diagn Microbiol Infect Dis; 2012 Dec; 74(4):412-4. PubMed ID: 23102558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
